Seattle, WA, United States of America

Sagar D Khare


Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • New Brunswick, NJ (US) (2017)
  • Seattle, WA (US) (2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sagar D Khare: Innovator in Biochemical Research

Introduction

Sagar D Khare is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemical research, particularly in the development of polypeptides and their applications in treating organophosphate exposure.

Latest Patents

Khare holds 2 patents that showcase his innovative work. His latest patents include "Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage." This patent describes a genetically modified polypeptide with enhanced catalytic efficiency for V-type nerve agents. Another notable patent is for "High affinity digoxigenin binding proteins," which involves isolated polypeptides with steroid binding activity, useful as therapeutics and detection agents.

Career Highlights

Throughout his career, Khare has worked with esteemed institutions such as the University of Washington and Yeda Research and Development Company. His work has focused on advancing the understanding of biochemical processes and developing practical applications for his discoveries.

Collaborations

Khare has collaborated with notable scientists, including David Baker and Dan S Tawfik. These collaborations have further enriched his research and contributed to the advancement of his innovative projects.

Conclusion

Sagar D Khare is a distinguished inventor whose work in biochemical research has led to significant advancements in the field. His patents reflect his commitment to innovation and the potential for real-world applications in health and safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…